Moskowitz Howard S, Heuser John, McGraw Timothy E, Ryan Timothy A
Department of Biochemistry, Weill Medical College of Cornell University, New York, New York 10021, USA.
Mol Biol Cell. 2003 Nov;14(11):4437-47. doi: 10.1091/mbc.e03-04-0230. Epub 2003 Aug 7.
The accurate assignment of molecular roles in membrane traffic is frequently complicated by the lack of specific inhibitors that can work on rapid time scales. Such inhibition schemes would potentially avoid the complications arising from either compensatory gene expression or the complex downstream consequences of inhibition of an important protein over long periods (>12 h). Here, we developed a novel chemical tool to disrupt clathrin function in living cells. We engineered a cross-linkable form of clathrin by using an FK506-binding protein 12 (FKBP)-clathrin fusion protein that is specifically oligomerized upon addition of the cell-permeant cross-linker FK1012-A. This approach interrupts the normal assembly-disassembly cycle of clathrin lattices and results in a specific, rapid, and reversible approximately 70% inhibition of clathrin function. This approach should be applicable to a number of proteins that must go through an assembly-disassembly cycle for normal function.
由于缺乏能在快速时间尺度上起作用的特异性抑制剂,准确确定膜运输中的分子作用常常变得复杂。这样的抑制方案可能会避免因补偿性基因表达或长期(>12小时)抑制重要蛋白质所产生的复杂下游后果而引发的并发症。在此,我们开发了一种新型化学工具来破坏活细胞中的网格蛋白功能。我们通过使用FK506结合蛋白12(FKBP)-网格蛋白融合蛋白构建了一种可交联形式的网格蛋白,该融合蛋白在添加可穿透细胞的交联剂FK1012-A后会特异性寡聚化。这种方法中断了网格蛋白晶格的正常组装-拆卸循环,并导致网格蛋白功能出现约70%的特异性、快速且可逆的抑制。这种方法应该适用于许多必须经历组装-拆卸循环才能正常发挥功能的蛋白质。